What Medmo does
Medmo runs an AI-powered care-coordination platform that manages the full medical-imaging referral journey for physicians, imaging centers, hospitals and payers, covering patient engagement, scheduling, prior authorization and results collection. The company says it has facilitated more than 1 million patient journeys and operates with every imaging center and hospital in the country, working across MRI, CT, mammography, ultrasound and X-ray exams in all 50 states. Medmo reports its platform cuts imaging costs by more than 25%, improves appointment completion rates by 30%, and reduces staff scheduling time by 95%.
Medmo is a healthcare tool on Falcoscan. AI-powered orchestration platform for medical imaging referrals and scheduling. Falcoscan rates Medmo with an Opportunity score of 84/100, a Saturation score of 11/100, and a Wrapper-risk score of 9/100. Market signal: rising. Medmo is founded in 2017, currently at Series_a stage. Pricing: Paid.